CVE-2020-24677

Insecure Web Service in Symphony Plus

Description

Vulnerabilities in the S+ Operations and S+ Historian web applications can lead to a possible code execution and privilege escalation, redirect the user somewhere else or download unwanted data.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 1.14% Top 25%
Vendor Advisory abb.com Vendor Advisory abb.com
Affected: ABB ABB Ability™ Symphony® Plus Operations
Affected: ABB ABB Ability™ Symphony® Plus Historian
Published at:
Updated at:

References

Link Tags
https://search.abb.com/library/Download.aspx?DocumentID=2PAA123980&LanguageCode=en&DocumentPartId=&Action=Launch mitigation vendor advisory
https://search.abb.com/library/Download.aspx?DocumentID=2PAA123982&LanguageCode=en&DocumentPartId=&Action=Launch mitigation vendor advisory

Frequently Asked Questions

What is the severity of CVE-2020-24677?
CVE-2020-24677 has been scored as a high severity vulnerability.
How to fix CVE-2020-24677?
To fix CVE-2020-24677, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-24677 being actively exploited in the wild?
It is possible that CVE-2020-24677 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-24677?
CVE-2020-24677 affects ABB ABB Ability™ Symphony® Plus Operations, ABB ABB Ability™ Symphony® Plus Historian.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.